Investigating the burden of hypertension and diabetes in an HIV+ population in Malawi.
Context
In Malawi, hypertension (HT) and diabetes mellitus (DM) are common among HIV+ patients, especially those on antiretroviral therapy (ART). HT and DM can lead to serious complications such as stroke, heart disease, kidney failure and blindness.
In Malawi, HT and DM often go undiagnosed and therefore untreated. In the coming years, HT and DM are likely to have an even larger burden due to urbanization, prolonged life expectancy, increasing wealth and associated dietary changes in Malawi and throughout sub-Saharan Africa.
It is projected that the number of HT patients in this region will double between 2000 and 2025. HT and DM are common reasons for hospital admissions throughout the country, but the prevalence and incidence of these conditions in HIV+ patients are not well studied.
Aim
The aim of the study is to estimate the prevalence of HT, DM and cardiovascular risk factors among people living with HIV in Zomba District, Malawi using a cross-sectional analysis of 942 patients. The number of patients already enrolled in HIV care but in need of integrated treatment will also be estimated.
Sites
Timeline
January 2014 – December 2014
Partnerships
Funder: Canadian Institutes of Health Research (CIHR)
Study Lead: Dignitas International
Partner: University of Malawi – College of Medicine
Study Team
Dr. Sumeet Sodhi
Co-Principal Investigator, Dignitas International
Dr. Joep van Oosterhout
Co-Principal Investigator, Dignitas International
Oscar Divala
Study Coordinator, Dignitas International
